Temozolomide based treatment in glioblastoma: 6 vs. 12 months.
Fasano M, Pirozzi M, De Falco V, Miceli CC, Farese S, Zotta A, Famiglietti V, Vitale P, Di Giovanni I, Brancati C, Carfora V, Solari D, Somma T, Cavallo LM, Cappabianca P, Conson M, Pacelli R, Ciardiello F, Addeo R.
Fasano M, et al. Among authors: de falco v.
Oncol Lett. 2024 Jul 2;28(3):418. doi: 10.3892/ol.2024.14551. eCollection 2024 Sep.
Oncol Lett. 2024.
PMID: 39006948
Free PMC article.